English  |  正體中文  |  简体中文  |  2815992  
???header.visitor??? :  27530895    ???header.onlineuser??? :  584
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"harzstark a"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-2 of 2  (1 Page(s) Totally)
1 
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2020-05-25T07:35:22Z Phase II results of dovitinib (TKI258) in patients with metastatic renal cell cancer Escudier B; Gr?nwald V; Ravaud A; Ou Y.-C; Castellano D; Chia-Chi Lin; Gschwend J.E; Harzstark A; Beall S; Pirotta N; Squires M; Shi M; Angevin E.
臺大學術典藏 2013 Phase i study of dovitinib (TKI258), an oral FGFR, VEGFR, and PDGFR inhibitor, in advanced or metastatic renal cell carcinoma Lopez-Martin J.A; Chia-Chi Lin; Gschwend J.E; Harzstark A; Castellano D; Soria J.-C; Sen P; Chang J; Shi M; Kay A; Escudier B.; Angevin E

Showing items 1-2 of 2  (1 Page(s) Totally)
1 
View [10|25|50] records per page